← Back to screener

IDEXX LABORATORIES INC /DE IDXX

Rank #1380 · Nasdaq · $43.5B market cap
Audited by PricewaterhouseCoopers LLP, no going-concern flag in the latest filing.
Score
49.1
P/E
51.5
P/B
71.43
ROE
138.8%
Op. Margin
30.0%
Debt Ratio
279%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆
Weak

P/E 51.5x, P/B 71.43x. Ranks in the top 73% of the universe.

Profitability ★★★★★
Excellent

ROE 138.8%. Ranks in the top 5% of the universe.

Safety ★★☆☆☆
Weak

Debt ratio 279%. Ranks in the top 70% of the universe. Above 200% signals meaningful leverage risk.

Growth ★★★☆☆
Good

Revenue growth of 8.7% year over year. Ranks in the top 38% of the universe.

Profitability is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2011–$0.2B$0.1B$0.6B–56
2012–$0.2B$0.1B$0.5B–91
2013–$0.2B$0.2B$0.6B–73
2014–$0.3B$0.2B$0.5B–137
2015–$0.3B$0.2B$0.1B–1078
2016–$0.3B$0.2B$-0.1B–-1853
2017–$0.3B$0.2B$-0.1B–-1513
2018$1.8B$0.4B$0.2B$-0.1B19.7-3266
2019$2.0B$0.4B$0.3B$-0.0B21.0-16258
2020$2.2B$0.5B$0.4B$0.2B22.2932
2021$2.4B$0.6B$0.4B$0.6B23.0263
2022$2.7B$0.7B$0.6B$0.7B25.7253
2023$3.2B$0.9B$0.7B$0.6B29.0351
2024$3.4B$0.9B$0.7B$0.7B26.7257
2025$3.7B$1.1B$0.8B$0.6B30.0279

← See the full screener